MMP9 and asthma: TIMP-1, also elevated in presence of a dominant pathogen, possesses antiprotease activity, and MMP-9:TIMP-1 ratio is reduced in asthma and chronic bronchitis43, correlating inversely with airflow obstruction, with TIMP-1 polymorphisms associated with female asthma44.